Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06486337 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CMOP±R in the Treatment of Untreated Non-Hodgkin's Lymphoma

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years later Aug 31, 2025 → Aug 31, 2027
See other at-risk trials from The First Affiliated Hospital of Soochow University

Record History

  1. Primary completion pushed from Aug 31, 2025 to Aug 31, 2027
    • Recruitment opened
    • Study sites: 0 to 1
    • Start date changed from estimate of Jul 10, 2024 to Jul 8, 2024
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a prospective, single arm, multicenter study to evaluate the safety and efficacy of CMOP±R in patients with newly diagnosed non-Hodgkin's lymphoma.
Trial Details
NCT Number NCT06486337
Lead Sponsor The First Affiliated Hospital of Soochow University
Conditions
(from sponsor)		 NHL
Enrollment 197 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov